Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trial NCT03500549 · COMPLETED
Trial details
- NCT number
- NCT03500549
- Sponsor
- Apellis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-14
- Primary completion
- 2019-11-14
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.